Langerhans cell histiocytosis epidemiology and demographics: Difference between revisions

Jump to navigation Jump to search
No edit summary
No edit summary
Line 1: Line 1:
__NOTOC__
__NOTOC__
{{Langerhans cell histiocytosis}}
{{Langerhans cell histiocytosis}}
{{CMG}}
{{CMG}}; {{AE}} {{NM}}
 
Please help WikiDoc by adding more content here.  It's easy!  Click  [[Help:How_to_Edit_a_Page|here]]  to learn about editing.
 
==Overview==
==Overview==
== Epidemiology ==
==Epidemiology==
LCH histiocytosis usually affects children of between 1 and 15 years old and peak incidence is between age 5 and 10.  Among children under the age of 10, yearly incidence is thought to be 1 in 200,000<ref>{{cite web |url=http://www.nlm.nih.gov/medlineplus/ency/article/000068.htm |title=MedlinePlus Medical Encyclopedia: Histiocytosis |accessdate=2007-05-10 |format= |work=}}</ref>; and in adults even more rare, in about 1 in 560,000.<ref>{{cite web|url=http://www.histiocytosis.ca/facts.html | title=Histiocytosis Association of Canada | accessdate=2007-05-16|format= |work=}}</ref> It has been reported in elderly but is vanishingly rare<ref>{{cite journal |author=Gerlach B, Stein A, Fischer R, Wozel G, Dittert D, Richter G |title=[Langerhans cell histiocytosis in the elderly] |language=German |journal=Der Hautarzt; Zeitschrift für Dermatologie, Venerologie, und verwandte Gebiete |volume=49 |issue=1 |pages=23-30 |year=1998 |pmid=9522189}}</ref>. commoner in white race and boys are effected twice as often as girls.
===Prevalence===
 
===Incidence===
LCH is usually sporadic and non-[[hereditary]] condition but familial clustering has been noted in limited number of cases. Hashimoto-Pritzker disease, a variant of Hand-Schüller-Christian disease, is a congenital self-healing form<ref>{{cite journal |author=Kapur P, Erickson C, Rakheja D, Carder K, Hoang M |title=Congenital self-healing reticulohistiocytosis (Hashimoto-Pritzker disease): ten-year experience at Dallas Children's Medical Center |journal=J. Am. Acad. Dermatol. |volume=56 |issue=2 |pages=290-4 |year=2007 |pmid=17224372}}</ref>.
===Age===
 
===Gender===
===Race===
==References==
==References==
{{Reflist|2}}
{{Reflist|2}}

Revision as of 15:58, 21 December 2015

Langerhans cell histiocytosis Microchapters

Home

Patient Information

Overview

Historical Perspective

Classification

Pathophysiology

Causes

Differentiating Langerhans cell histiocytosis from other Diseases

Epidemiology and Demographics

Risk Factors

Screening

Natural History, Complications and Prognosis

Diagnosis

History and Symptoms

Physical Examination

Laboratory Findings

Chest X Ray

CT

MRI

Echocardiography or Ultrasound

Other Imaging Findings

Other Diagnostic Studies

Treatment

Medical Therapy

Surgery

Primary Prevention

Secondary Prevention

Cost-Effectiveness of Therapy

Future or Investigational Therapies

Case Studies

Case #1

Langerhans cell histiocytosis epidemiology and demographics On the Web

Most recent articles

Most cited articles

Review articles

CME Programs

Powerpoint slides

Images

American Roentgen Ray Society Images of Langerhans cell histiocytosis epidemiology and demographics

All Images
X-rays
Echo & Ultrasound
CT Images
MRI

Ongoing Trials at Clinical Trials.gov

US National Guidelines Clearinghouse

NICE Guidance

FDA on Langerhans cell histiocytosis epidemiology and demographics

on Langerhans cell histiocytosis epidemiology and demographics

Langerhans cell histiocytosis epidemiology and demographics in the news

Blogs on Langerhans cell histiocytosis epidemiology and demographics

Directions to Hospitals Treating Langerhans cell histiocytosis

Risk calculators and risk factors for Langerhans cell histiocytosis epidemiology and demographics

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Nawal Muazam M.D.[2]

Overview

Epidemiology

Prevalence

Incidence

Age

Gender

Race

References


Template:WikiDoc Sources